Robert F. Kennedy Jr. is not qualified to be health and human services secretary for many reasons, chief among them being his years-long unscientific campaign against essential vaccines. Last week, he added a new one: His refusal to rectify a blatant conflict of interest.
In a harsh letter to lawmakers considering Robert F. Kennedy Jr.’s nomination for health secretary, Ms. Kennedy called her cousin unfit for the job and a “predator” who led family members to addiction.
RFK Jr. played a lead role in building an case against Merck's HPV vaccine and could profit from the lawsuit alleging fraud, even if confirmed as health secretary.
Calling Robert F. Kennedy Jr. a ''predator'' who is addicted to power, Caroline Kennedy urged the U.S. Senate in a Tuesday letter to reject the nomination of her cousin to be President Donald Trump's
Kennedy Jr., President Trump's pick for health secretary, has falsely linked vaccines to autism and argued people should have separate vaccination schedules based on their race.
A conservative group founded by former Vice President Mike Pence released an ad showing President Donald Trump calling Robert F. Kennedy Jr. “a radical left plant,” as the group urges Republicans to vote against Kennedy as nominee for Health and Human Services Secretary.
Many health professionals are lining up against Trump's pick for health secretary. They say his anti-vaccine views could cost lives. Some of his supporters embrace his stance.
Kennedy Jr. took to social media to appeal to his hundreds of thousands of followers on Facebook. The son of the late U.S. Attorney General and New York Sen. Bobby Kennedy and nephew of President John F.
Robert F. Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, Merck, if confirmed.
President-elect Donald Trump's pick to lead HHS has a long history of discounting and peddling misinformation about the HPV vaccine.
(Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil vaccine, a strategy that faces its first test in a Los Angeles court next week, according to two attorneys close to the case and court filings.